Cargando…

Spaeth/Richman Contrast Sensitivity in Staging Glaucoma

PURPOSE: To investigate contrast sensitivity measures in glaucoma eyes with moderate to severe glaucoma. METHODS: The study included 50 eyes of 47 pseudophakic patients with moderate or severe glaucoma who were seen at a tertiary center from 2017 to 2020. Assessment of contrast sensitivity using the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Aparna, Pal, Anindita, Mohapatra, Shreya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757629/
https://www.ncbi.nlm.nih.gov/pubmed/33384893
http://dx.doi.org/10.1167/tvst.9.13.39
_version_ 1783626773718630400
author Rao, Aparna
Pal, Anindita
Mohapatra, Shreya
author_facet Rao, Aparna
Pal, Anindita
Mohapatra, Shreya
author_sort Rao, Aparna
collection PubMed
description PURPOSE: To investigate contrast sensitivity measures in glaucoma eyes with moderate to severe glaucoma. METHODS: The study included 50 eyes of 47 pseudophakic patients with moderate or severe glaucoma who were seen at a tertiary center from 2017 to 2020. Assessment of contrast sensitivity using the Spaeth/Richman contrast sensitivity (SPARCS) test and the Pelli–Robson (PR) chart was compared in eyes with mean deviation (MD) < –12 decibels (dB) and > –20 dB (group 1), MD < –20 dB and > –30 dB (group 2), or MD < –30 dB (group 3). Multivariate regression analysis was used to analyze the association of visual field MD with SPARCS/PR scores and various clinical variables, including age, diagnosis, and logMar visual acuity. RESULTS: SPARCS total scores and quadrant-wise scores were significantly different in all of the quadrants, whereas central scores and PR contrast sensitivity were similar across groups. The total SPARCS scores predicted the change in MD (β = 0.5, P < 0.001, R(2) = 61.8%) with minimal association of other quadrantic or PR scores. Total SPARCS scores of <45 and <38 predicted severe glaucoma with MD crossing –20 dB (sensitivity, 70.5%; specificity, 80.9%) and –30 dB (sensitivity, 79.3%; specificity, 77.7%), respectively. The logMar visual acuity did not correlate with any contrast sensitivity measure or clinical variables in this study. CONCLUSIONS: The total SPARCS score may be used in staging glaucoma severity and to assess visual function in eyes with severe glaucoma. TRANSLATIONAL RELEVANCE: The SPARCS test is a useful tool for assessing visual function in advanced glaucoma beyond MD worse than –20 dB or –30 dB.
format Online
Article
Text
id pubmed-7757629
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-77576292020-12-30 Spaeth/Richman Contrast Sensitivity in Staging Glaucoma Rao, Aparna Pal, Anindita Mohapatra, Shreya Transl Vis Sci Technol Article PURPOSE: To investigate contrast sensitivity measures in glaucoma eyes with moderate to severe glaucoma. METHODS: The study included 50 eyes of 47 pseudophakic patients with moderate or severe glaucoma who were seen at a tertiary center from 2017 to 2020. Assessment of contrast sensitivity using the Spaeth/Richman contrast sensitivity (SPARCS) test and the Pelli–Robson (PR) chart was compared in eyes with mean deviation (MD) < –12 decibels (dB) and > –20 dB (group 1), MD < –20 dB and > –30 dB (group 2), or MD < –30 dB (group 3). Multivariate regression analysis was used to analyze the association of visual field MD with SPARCS/PR scores and various clinical variables, including age, diagnosis, and logMar visual acuity. RESULTS: SPARCS total scores and quadrant-wise scores were significantly different in all of the quadrants, whereas central scores and PR contrast sensitivity were similar across groups. The total SPARCS scores predicted the change in MD (β = 0.5, P < 0.001, R(2) = 61.8%) with minimal association of other quadrantic or PR scores. Total SPARCS scores of <45 and <38 predicted severe glaucoma with MD crossing –20 dB (sensitivity, 70.5%; specificity, 80.9%) and –30 dB (sensitivity, 79.3%; specificity, 77.7%), respectively. The logMar visual acuity did not correlate with any contrast sensitivity measure or clinical variables in this study. CONCLUSIONS: The total SPARCS score may be used in staging glaucoma severity and to assess visual function in eyes with severe glaucoma. TRANSLATIONAL RELEVANCE: The SPARCS test is a useful tool for assessing visual function in advanced glaucoma beyond MD worse than –20 dB or –30 dB. The Association for Research in Vision and Ophthalmology 2020-12-22 /pmc/articles/PMC7757629/ /pubmed/33384893 http://dx.doi.org/10.1167/tvst.9.13.39 Text en Copyright 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Article
Rao, Aparna
Pal, Anindita
Mohapatra, Shreya
Spaeth/Richman Contrast Sensitivity in Staging Glaucoma
title Spaeth/Richman Contrast Sensitivity in Staging Glaucoma
title_full Spaeth/Richman Contrast Sensitivity in Staging Glaucoma
title_fullStr Spaeth/Richman Contrast Sensitivity in Staging Glaucoma
title_full_unstemmed Spaeth/Richman Contrast Sensitivity in Staging Glaucoma
title_short Spaeth/Richman Contrast Sensitivity in Staging Glaucoma
title_sort spaeth/richman contrast sensitivity in staging glaucoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757629/
https://www.ncbi.nlm.nih.gov/pubmed/33384893
http://dx.doi.org/10.1167/tvst.9.13.39
work_keys_str_mv AT raoaparna spaethrichmancontrastsensitivityinstagingglaucoma
AT palanindita spaethrichmancontrastsensitivityinstagingglaucoma
AT mohapatrashreya spaethrichmancontrastsensitivityinstagingglaucoma